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Abstract 
Background: Euglena tuba, a microalga, is known for its excellent antioxidant and iron-chelation activities; however 
its anticancer efficacies have not been reported yet. This study investigates the antitumor and antimetastatic activities 
of 70 % methanolic extract of Euglena tuba (ETME) against human lung (A549) and breast cancer (MCF-7) cells in vitro. 
Moreover, we had examined ETME’s role in inducing intracellular ROS with the regulation of antioxidants and MAPK 
pathway.
Methods: Anticancer activity of ETME was thoroughly studied using flow cytometry, confocal microscopy and west-
ern blotting; along with various biochemical assays for analysing ROS-induced regulation of antioxidant enzymes. 
Inhibition of invasion and migration of malignant cells by ETME were investigated by wound healing and zymo-
graphic studies. DNA–Protein interaction with ETME was also studied.
Results: ETME inhibited the growth of both A549 (IC50 92.14 µg/ml) and MCF-7 cells (IC50 50.27 µg/ml) by induc-
ing apoptosis, while remained non-toxic against nomral WI-38 cells (IC50 911.43 µg/ml). ETME treatment resulted in 
increasing Bax/Bcl-2 ratio, BID truncation and activation of caspase cascade. This ultimately leads to PARP degradation 
and apoptosis through the intrinsic and extrinsic pathway in both A549 and MCF-7 cells. Wound healing and gelatin 
zymography studies revealed that ETME significantly inhibited the invasion and migration of both A549 and MCF-7 
cells dose-dependently through the downregulation of MMP-9. Further investigations showed that ETME selectively 
induces intracellular ROS, regulated the levels of intracellular antioxidants and suppresses the activation of ERK1/2, 
JNK, P38 mitogen-activated protein kinase pathways in both type of malignant cells. Further DNA and protein bind-
ing studies revealed that ETME strongly interact with DNA as well as protein attributing the possibilities of presence 
of components which are targeting the macromolecules in cancer cells. Moreover, when the identified compounds 
from ETME were examined for their cytotoxicities individually, it was found that they lost their specificities towards 
cancer cells and also attacked normal cells.
Conclusions: Our study suggests that ETME retards the growth of both lung and breast cancer cells, in vitro, through 
multivariate mechanisms, proving its candidature for the development of better and safer drugs against these 
cancers.
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Background
In the last era, many diseases have overcome through 
the significant improvement of biomedical science. 
However, cancer remains elusive, especially from a ther-
apeutic viewpoint. Currently, cancer is treated using radi-
otherapy, chemotherapy and surgery that are related with 
severe side effects [1]. Even a large number of tumours 
are insufficiently responsive to cancer therapeutic drugs 
and radiotherapy due to multi-drug resistance. Epidemio-
logic studies suggests that in dietary supplement, increas-
ing consumption of fruits, vegetables, whole grains and 
related lifestyles is a practical approach for significantly 
reducing the incidence of cancer. Numerous individual 
phytochemicals (>5000) are isolated from the plant-based 
foods [2]. Before we can fully understand the health ben-
efits in humans, their identification, characterization and 
mechanism of action need to be determined. In mam-
malian cells, biological targets of phytochemicals were 
found to be involved in antiproliferative, anti-inflamma-
tory, antiangiogenic, antimetastatic and pro-apoptotic 
effects, or the ability to reduce oxidative stress [3, 4]. 
In vitro studies on different cancer cell lines proved the 
role of polyphenols as growth inhibitors, either by induc-
tion of G1-cell cycle arrest [5], G2/M arrest [6], or cell 
death [7]. Similarly, different carotenoids demonstrated 
G-1 arrest [8] and apoptosis [9] in various cancer cells. 
So, identification and development of natural resources 
used for cancer treatment have attracted a lot of attention 
globally.
Reactive oxygen species (ROS), a regular by-product of 
the normal breakdown of oxygen, play a significant role 
in normal biochemical functions and abnormal patho-
logical processes [10]. There is a subtle balance between 
intracellular ROS and antioxidant capacity in normal 
cells, which determines their destiny [11]. Yet cancer cells 
are characterised by elevated intracellular ROS stress, 
resulting from carcinogenesis stimulation, abnormal 
metabolic activity and mitochondrial malfunction. The 
limited capacity of tumor cells to deal with the elevated 
ROS levels makes them vulnerable to oxidative stress 
[12]. This embarks a novel strategy for cancer therapy to 
promote apoptosis in cancer cells by eliminating the abil-
ity of antioxidant defence systems through inducing ROS 
production [13].
Euglena tuba (Carter) (Family, Euglenaceae) is one 
of the most widespread microalga in the Rarh region of 
West Bengal, India. Cells of E. tuba are normally green, 
having periplast without spiral rows of granules and 
more than one chloroplast. Paramylon bodies are pre-
sent but margins not convolute, with cylindrical and 
highly metabolic cells that constantly change shapes in 
movements as they have stiff blue pellicle outside the cell 
membrane that are flexible in nature [14]. Euglena mainly 
grows in aquatic bodies with algal bloom all over the 
year mostly in winter. Various Euglena sp. have a broad 
range of medicinal properties, such as antimicrobial, 
anti-mutagenic, anti-HIV, immunopotentiating and anti-
tumor activity [15–20] with numerous isolated bioactive 
compounds such as, vitamin C, vitamin E and β-carotene 
that can be harnessed for commercial use [21]. In our 
previous study, we reported that E. tuba possess potent 
in  vitro antioxidant and in  vivo iron chelation activity 
[22, 23] and numerous phytochemicals such as phenolics, 
flavonoids, alkaloids, tannins, terpenoids, triterpenoids, 
saponin, glycoside and carbohydrates are present in 
adequate amount in the extract which was confirmed by 
phytochemical analysis [22]. In this study, we first dem-
onstrated the antiproliferative effect of 70 % methanolic 
extract of E. tuba (ETME) on lung and breast cancer cells 
and normal fibroblast cells in  vitro. Moreover, we have 
studied that ROS accumulation caused by ETME leads 
to the activation of apoptosis and inhibition of metastasis 
through regulation of MAPK pathways.
Results
ETME has antiproliferative activity against cancer cells, not 
in normal cells
Cytotoxic effect of ETME was investigated on lung 
(A549) and breast (MCF-7) carcinoma and also on one 
non-malignant cell line (WI-38) using WST-1 assay. As 
shown in Fig. 1, ETME was found cytotoxic against both 
A549 and MCF-7 cells and inhibited their growth dose-
dependently with an IC50 value of 92.14 and 50.27 µg/ml 
respectively. However, the treatment of ETME did not 
significantly inhibit the cell propagation of WI-38 cells 
which is corroborated by high IC50 value (911.43 µg/ml).
Fig. 1 Effect of ETME on cell viability and growth of A549, MCF-7 and 
WI-38 cells. WST-1 assay of all cells treated with different concentra-
tions of ETME and incubate for 48 h. Results were expressed as cell 
viability (% of control). All data is expressed as mean ± SD (n = 6). 
*p < 0.05 and ***p < 0.001 vs. 0 µg/ml
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Cell cycle analysis by flow cytometry
The effect of ETME on cell cycle distribution of A549 and 
MCF-7 cells was studied. Figure  2a–d show that ETME 
has capablity to induce cell death in A549 cells at 200 µg/
ml and MCF-7 cells at 150  µg/ml concentration. After 
treatment with ETME, the populations in every phase 
(sub-G1, G1, S, G2/M) were quantified and plotted with 
increasing doses. It is found that, nearly 33.88 and 22.68 % 
cells were accumulated in Sub-G1 phase (apoptotic phase) 
in A549 (200 µg/ml) and MCF-7 (150 µg/ml) cells respec-
tively. This increasing Sub-G1 phase also coincides with 
the decrease in the cell population of other phases.
ETME induces apoptosis by Annexin V/PI study and DAPI 
staining
We next investigated whether ETME could induce apop-
tosis in both A549 and MCF-7 cells. After 48 h of ETME 
treatment the percentage of apoptotic cells increased, 
Fig. 2 Flow cytometric analysis of A549 and MCF-7 cells treated with ETME (0–200 µg/ml). a Cell cycle phase distribution of A549 cells treated with 
indicated doses for 48 h, b Graphical representation of  % cell population in all phases (Sub-G1, G1, S, and G2/M) for section A, c The phase of cell 
cycle distribution of MCF-7 cells after ETME treatment with indicated doses for 48 h, d Graphical representation of  % cell population in all phases 
(Sub-G1, G1, S, and G2/M) for section B, e Apoptosis detection of A549 cells treated with indicated doses for 48 h, f Apoptosis detection of MCF-7 
cells treated with indicated doses for 48 h
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from 0.13  % in the control to 71.36  % (200  μg/ml) in 
case of A549 (Fig. 2e) and from 0.46 % in the control to 
94.65  % (200  μg/ml) in MCF-7 cells (Fig.  2f ). Both the 
untreated and ETME (200  μg/ml for A549 and 150  μg/
ml for MCF-7) treated cells were stained using DAPI and 
pictures were captured by confocal microscopy (Fig. 3a). 
Untreated cells were found with normal morphology and 
intact nuclei, while the treated cells exhibited the char-
acteristics of apoptosis, with condensed and fragmented 
nuclei.
ETME regulates the Bax/Bcl‑2 ratio and activates caspases 
in both A549 and MCF‑7 Cells
To know the underlying mechanism responsible for 
ETME-induced apoptosis, we next examined numerous 
proteins that are involved in the regulation of apoptosis 
in A549 and MCF-7 cells by Western blot analysis. We 
found that ETME upregulated the expression of Bax and 
downregulated the expression of Bcl-2 in a time-depend-
ent manner, leading to increase in the Bax/Bcl-2 ratio in 
both cells. Activation of different caspases like caspase-3, 
caspase-8, caspase-9, truncation of BID and degradation 
of PARP after 12 h of ETME treatment (Fig. 3b, c) in both 
A549 and MCF-7 cells, are hallmarks of apoptosis.
Effect of ETME on cell migration
The effect of ETME on A549 and MCF-7 cell migration 
was determined by scratch motility assay. After 48  h, 
both the untreated A549 and MCF-7 cells displayed a 
complete wound closure activity (Fig.  4a, b). In con-
trary, ETME showed a decreasing migration of A549 and 
MCF-7 cells in a time-dependent study using the low 
dose which was confirmed by cell viability assay (100 μg/
ml for A549 and 80 μg/ml for MCF-7). Additionally, we 
investigate the inhibitory effect of ETME on the upregu-
lation of MMP-9 through gelatin zymography. As shown 
in Fig. 4c, d, MMP-9 expression was inhibited by ETME 
with increasing dose. We found that the expression of 
MMP-9 decrease after treatment with 100 μg/ml in A549 
and 80 μg/ml in MCF-7 cells.
ETME increases ROS levels in both cancer cells, not 
in normal cells
To examine whether ETME has any effect on ROS level 
in A549, MCF-7 and WI-38 cells, we used fluorescent 
dye (DCFH-DA) to determine the intracellular ROS 
level in the presence or absence of ETME. As shown in 
Fig.  5a, both cells that were treated with 0-200  μg/ml 
ETME for 24  h had remarkably increasing ROS levels 
than normal WI-38 cells. ROS levels were showed to be 
increased by 1.92 (100 μg/ml), 2.62 (150 μg/ml) and 3.15-
folds (200 μg/ml) in case of A549 cells and 2.42 (100 μg/
ml), 2.63 (150 μg/ml) and 3.01-folds (200 μg/ml) in case 
of MCF-7 cells by ETME over that in untreated cells. In 
confocal microscopy study, the significant stimulation 
of ROS was also observed by ETME in A549 and MCF-7 
cells (Fig.  5b), it means that the stimulation of ROS by 
ETME could be specific to both cancer cells.
ETME regulates the levels of intracellular antioxidants
To determine whether ETME has any effect on antioxi-
dant enzymes level in A549, MCF-7 and WI-38 cells, we 
checked the levels of these proteins along with GSH and 
TBARS. From Fig. 5c–g we found that SOD (4.56 fold), 
catalase (1.79 fold), GST (21 fold) and TBARS (2.57 fold) 
level increased in MCF-7 cells and GSH (1.13 fold), GST 
(9.13 fold), TBARS (1.67 fold) level increased in A549. 
Remarkably, ETME suppresses the enzyme expression 
of SOD (0.6 fold), CAT (0.8 fold) in A549 cells and GSH 
(0.2 fold) level in MCF-7 cells. Beside slight change in 
GST level, all the other antioxidants remain unchanged 
in WI-38 cells.
Role of MAPK in ETME‑induced ROS
Numerous anticancer compounds promote ROS pro-
duction and regulate MAPK signalling and finally cause 
apoptosis [24]. We next studied the phosphorylation 
(activation) status of the ERK 1/2, p38 MAPK, JNK and 
expression level of tumour suppressor p53. Both A549 
and MCF-7 cells were exposed to ETME for several time 
lengths (0–36 h) and the activations of the ERK 1/2, p38 
MAPK and JNK pathways were determined by western 
blot analysis. The levels of pERK 1/2, p-p38 MAPK, pJNK 
and p53 were gradually decreased in A549 cells (Fig. 5h) 
and the same are also downregulated in MCF-7 cells 
except p53 (Fig. 5h). In case of MCF-7 cells, p53 is upreg-
ulated up to 12 h followed by downregulation in case of 
further incubation.
ETME interacts with DNA and protein
The UV–vis absorption spectra of ds DNA and denatured 
DNA (ss DNA) in the presence and absence of ETME are 
illustrated in Fig. 6a, b. It was observed that the absorb-
ance (215 and 260  nm) elevated by increase in ETME 
concentration in both cases of DNA.
In case of UV–vis absorption spectra BSA possessed two 
absorption peaks at 220 and 280 nm, as shown in Fig. 6c 
and BSA possessed one soret peak at 340 nm in fluores-
cence spectra (Fig. 6d). In case of UV–vis absorption spec-
tra, the increasing trend of absorption peaks was observed 
with increasing concentration of ETME. In addition in flu-
orescence spectra the decreasing trend also follows.
Synergistic effect of bioactive compounds present in ETME
Previously, we reported that higher quantity of fla-
vonoids, with considerable quantities of alkaloids, 
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Fig. 3 Observation of DNA fragmentation and westerblot analysis of apoptotic proteins in ETME treated A549 and MCF-7 cells. a The fragmented 
DNA of nuclei were bind with DAPI and observed under a confocal microscope (630×). The white arrows indicate cells with fragmented DNA of 
nucleus after the treatment of ETME. b Effect of ETME on apoptotic proteins in A549 (200 µg/ml) cells and c MCF-7 (150 µg/ml) cells analysed by 
immunoblotting after various time intervals. Expression of β-actin was set as a protein loading control
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phenolics, carbohydrates, tannins and little quantity of 
ascorbic acid were present in ETME. Moreover, pres-
ence of probable active compounds such as ascorbic acid, 
catechin, methyl gallate, reserpine, rutin and tannic acid 
were detected through HPLC [22]. The cytotoxicity of 
these compounds was investigated individually against 
A549, MCF-7 and WI-38 cells. It was observed that tan-
nic acid, reserpine and methyl gallate showed promis-
sive cytotoxicity against A549, MCF-7 and WI-38 cells. 
Moreover, ascorbic acid, rutin, catechin showed negli-
gible cytotoxicity towards A549 and WI-38 cells while 
found toxic against MCF-7 cells (Fig. 7; Table 1). ETME, 
on the other hand, showed selective cytotoxicity against 
A549 and MCF-7 cells while being non-toxic to normal 
cells.
Discussion
Algae are an important source of different bioactive com-
pounds such as antioxidants, antivirals, antimicrobials 
etc. [25]. Many algae have shown cytotoxic and antitumor 
activities against different types of cancers [26]. These 
antitumor activities can play a significant role in devel-
opment of new pharmaceutical compounds as antitumor 
drugs [27]. In our study, ETME had been considered 
for its probable anticancer activity against two kinds of 
human tumor cell lines: A549, MCF-7. Results from this 
study demonstrated that ETME inhibited the growth of 
A549 and MCF-7 cells through the induction of apop-
tosis, while showed negligible cytotoxicity towards non-
malignant cells (WI-38). ETME promoted apoptosis in 
both type of cells with an effective dose 200  μg/ml for 
A549 and 150 μg/ml for MCF-7. Further, morphological 
study from DAPI staining also supported that the above-
mentioned doses of ETME are effective in inducing apop-
tosis in both types of cells.
In the modulation of apoptotic signalling pathways, 
caspases play important roles in cells and hence their 
survival and death. Moreover, the fate of cells towards 
survival or death relies on critical balance between Bcl-2 
(antiapoptotic) and Bax (pro-apoptotic) proteins. Time-
dependant increase of Bax/Bcl-2 ratio after the treat-
ment of ETME resulted in apoptosis through intrinsic 
pathway. ETME treatment further led to the downregu-
lation of pro-caspase 8 and upregulation of its active 
form along with formation of t-Bid on ETME treatment. 
Caspase 8  has been known to connect intrinsic and 
Fig. 4 Wound healing activity of untreated and treated A549 and MCF-7 cells observed under a light microscope (100×). a Representative cell 
migration images of wounded A549 cells monolayer treated with ETME; b Representative cell migration images of wounded MCF-7 cells monolayer 
treated with ETME. c, d Effect of ETME on the secretions of MMP-9 in A549 and MCF-7 cells observed by gelatin zymography
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extrinsic apoptotic pathways via Bid cleavage to t-Bid, 
thus suggesting its importance in activation of both the 
pathways [28]. These results suggest that ETME regu-
lates various proteins involved in intrinsic and extrinsic 
pathways thereby inducing apoptosis. Ineffectiveness of 
presently existing treatments is generally due to the inva-
sive and metastatic abilities of malignant cancer cells. 
Numerous studies have established that suppression of 
these stages results in the prevention of metastasis and 
they are the targets of anticancer drug development. 
We found that ETME-treated cells exhibited downregu-
lated MMP-9 expression in both carcinomas, compared 
to the control cells. Additionally, a remarkable decrease 
of cell motility was also seen at a lesser toxic concentra-
tion of ETME, signifying its capability to inhibit cell’s 
motility. This capability of ETME to inhibit cell’s motil-
ity can be interconnected with its ability to inhibit the 
invasiveness of cells since suppression of MMP-9 activi-
ties had also been found to be able to reduce migra-
tion of cells. Evidences proposed that various natural 
compounds, for example curcumin and resveratrol, 
behave either as antioxidant or pro-oxidant depending 
on the concentration used and the aimed cells [29, 30]. 
Neferine could trigger mitochondrial-mediated ROS 
Fig. 5 ETME induces ROS by regulating intracellular antioxidants with suppression of MAPK pathways. ETME stimulates ROS generation in A549 
and MCF-7 cells, not in normal WI-38 cells. a Intracellular ROS levels were examined under FACS using the DCFH-DA staining method and pre-
sented graphically; b Intracellular ROS was also visualised under the confocal microscope with 400× magnification; ETME regulate levels of major 
antioxidants such as c SOD, d catalase, f GST, e GSH and g TBARS in A549 and MCF-7 cells compared to normal WI-38 cells. All data is expressed as 
mean ± SD (n = 6). *p < 0.05, **p < 0.01 and ***p < 0.001 vs. 0 µg/ml; h Western blot analysis of MAPKs and p53 of A549 and MCF-7 cells treated 
with 200 and 150 µg/ml of ETME respectively. Expression of β-actin was set as a protein loading control
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formation in inducing apoptosis in HepG2 cells [31]. 
Here, we observed that while ETME had an effective 
cytotoxicity on lung and breast cancer cells, it showed 
a negligible effect on normal human fibroblast cells. At 
the same time, our result suggested that ETME signifi-
cantly increased enormous ROS generation in both can-
cer cells, but failed to generate in WI-38 cells. A549 cells 
treated with ETME displayed increase in levels of GST 
and GSH as well as production of TBARS (cell damag-
ing index) while SOD and CAT activities decreased over 
48 h of treatment. In case of MCF-7 cells exposed with 
ETME, SOD, CAT, GST activity and TBARS produc-
tion is increased, while GSH level remained unaffected. 
There is a threshold of ROS above which cells cannot 
tolerate. A minimum increase of ROS levels in cancer 
cells can be toxic, making these cells more susceptible to 
ROS-induced cell death due to the failure of antioxidant 
defence mechanism [12]. But in case of catalase in A549 
cells, probably H2O2 suppress the transcription factor 
FoxO1 by PI 3 kinase/Akt-dependent phosphorylation, 
where PI 3 kinase/Akt signaling is essential for this nega-
tive regulation of catalase [32]. We speculated that sup-
pression of SOD gene transcription in A549 cells results 
possibly in lower activity of SOD leading to increase 
intracellular O2− levels and furthermore the OH pro-
duction through Fenton reaction known to initiate lipid 
peroxidation. Additionally, superoxide ions can prevent 
GPx activity through oxidative alterations [11]. GSH is 
an antioxidant and its reduction in intracellular levels in 
MCF-7 cells are connected with enriched susceptibility 
to ROS-induced apoptosis [33]. Surprisingly, in normal 
cells, the balance of antioxidants is maintained.
The MAPK family have important roles in cell survival 
and death. It is familiar that JNK, p38 and p53 trigger 
Fig. 6 UV visible spectra obtained with increasing concentrations of ETME interaction with Salmon sperm DNA. a dsDNA + ETME under native 
conditions (25 °C) and b ssDNA + ETME under denaturing conditions (95 °C). c UV-visible spectra obtained with increasing concentrations of ETME 
interaction with BSA protein at 25 °C. d Fluorescence spectra of BSA with various amounts of ETME (pH 7.4, 25 °C). λex = 288 nm, λem = 280–
500 nm. Conditions of each spectra are marked with appropriate numbering
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apoptosis while ERK helps cell survival [34]. Previous 
studies have shown that ERK is specially stimulated by 
mitogen through the involvement of Ras/Raf/MEK in 
MAPK pathways, thus leading to cell growth and survival 
[35]. Furthermore, JNK and p38 MAPK signalling mol-
ecules are predominantly activated depending upon the 
inflammatory cytokines and environmental stress, which 
ultimately helps in cell differentiation and apoptosis [36]. 
In this study, we observed a decreased p-ERK1/2, JNK 
and p38 in response to ETME treatment. In addition, JNK 
may have a role as an antiapoptotic protein kinase in few 
tumors. Antisense oligonucleotides, specific to JNK can 
lead to the reduction of its mRNA level, thereby restrict-
ing the growth of A549 cells, probably by promoting 
apoptosis [37]. Our report showed that phosphorylation 
of p38 was inhibited dose-dependently by ETME. This 
discrepancy may be due, at least in part, to the variation 
of cell type’s. In case of MCF-7 cells p53 was upregulated 
up to 12  h followed by downregulation after treatment 
with ETME might be due to the loss of cells indicating 
that ETME induces apoptosis in MCF-7 cells by activat-
ing p53. However, in case of A549 cells time dependent 
downregulation of p53 expression was observed sug-
gesting ETME induce p53 independent apoptosis in this 
type of cells. This regulation in MAPK pathways could be 
responsible for the activation of apoptotic pathways and 
inhibition of MMPs expression since inhibition of Ras 
in vitro has been shown to stop MMPs formation [38].
UV spectroscopy is widely adapted as a useful technique 
for studying drug–DNA and drug–protein interactions. 
The UV–visible spectra of ds and ss DNA show a promi-
nent absorption peak at 205 nm and slight red shift also 
observed after addition of increasing concentrations of 
ETME. Moreover, another peak i.e. 260 nm also increase 
in its intensity after ETME addition suggesting hyperchr-
omicity [39]. A continuous hyperchromicity of the soret 
band upon addition of ETME to ds DNA solution may be 
an indication of electrostatic binding or partial unwinding 
Fig. 7 Effect of various bioactive compounds such as a ascorbic acid, b catechin, c methyl gallate, d reserpine, e rutin and f tannic acid present in 
ETME on cell viability and growth of A549, MCF-7 and WI-38 cells using WST-1 assay. Results were expressed as cell viability (% of control). All data is 
expressed as mean ± SD (n = 6). *p < 0.05, **p < 0.01 and ***p < 0.001 vs. 0 µg/ml
Table 1 IC50 values of the identified compounds and ETME 
against A549, MCF-7 and WI-38 cells
All the IC50values are determined in µg/ml. Data expressed as mean ± SD (n = 6)
Sample A549 MCF‑7 WI‑38
Ascorbic acid 6018.19 ± 3435.95 79.14 ± 2.2 6802.54 ± 2248.78
Catechin 4010.65 ± 1849.57 256.52 ± 17.14 753.56 ± 31.99
Methyl gallate 77.25 ± 1.82 53.05 ± 1.91 344.1 ± 31.34
Reserpine 68.46 ± 1.73 57.26 ± 2.29 50.47 ± 1.48
Rutin 4175.01 ± 1608.96 271.3 ± 9.85 1230.51 ± 195.42
Tannic acid 302.25 ± 11.86 97.24 ± 4.89 308.32 ± 8.32
ETME 92.14 ± 6.57 50.27 ± 1.6 911.43 ± 212.2
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or intercalative mode of binding involving a strong stack-
ing interaction between an aromatic chromophore and 
the base pairs of DNA [40–42]. In order to understand the 
interaction of the ETME with denatured DNA, the DNA-
compound mixture was heated at 95  °C for 15 min. The 
resulting spectra (Fig.  6b) revealed a moderately lower 
hyperchromic shift than the native conditions. Under 
denatured conditions the DNA double helix uncoils, 
exposing more number of nitrogen bases to the medium 
which loss interface electrostatic interactions with the 
complexes present in ETME, indicating the presence of 
DNA intercalating agents in ETME.
In case of protein, UV–vis absorption measurement 
is a simple and relevant method that is used to investi-
gate structural changes and to discover complex forma-
tion [43, 44]. The elevated levels of absorbance after the 
addition of ETME indicate the formation of a ground 
state complex. As dynamic quenching does not affect the 
absorption spectrum of a molecule and it only affects the 
excited states of a molecule, the observed changes in BSA 
absorbance in the presence of different concentrations 
of ETME could be an indicative of occurrence of static 
quenching interaction between the compounds present 
in ETME and BSA [45]. Also, fluorescence spectroscopy 
has been regarded as the most comprehensive method 
for studying protein–ligand interactions especially in 
dynamic states [46]. Generally, BSA fluorescence absorp-
tion originates from Trp, Tyr and Phe residues, whereas 
its intrinsic fluorescence can be mainly attributed to the 
Trp residue alone [47]. The fluorescence intensity of BSA 
was decreased dose-dependently with increase in ETME 
concentrations (Fig.  6d) and no emission spectral shift-
ing was observed, indicating that ETME could interact 
with BSA, and that the fluorescence chromophores of 
BSA were not exposed to an obvious polarity change with 
ETME titration.
It was also described that no single class of compounds 
in an extract could be completely held accountable for 
the activity produced by the total extract itself [48]. Our 
result suggested that probable bioactive compounds pre-
sent in ETME, individually are not specific to kill cancer 
cells, they also affected the growth of normal cells. There-
fore, it is more significant as well as prudent to assess the 
activity of ETME as a complete mixture of interacting 
bioactive compounds rather than evaluating them as a 
breakup of their individual components.
Conclusions
Our findings indicated that mixture of bioactive com-
pounds present in ETME effectively inhibits the growth 
of A549 and MCF-7 cells without hampering the normal 
WI-38 cells. ETME induces the apoptosis and suppresses 
metastasis including cell migration and cell invasion 
through the elevation of intracellular ROS levels follow-
ing suppression of MAPK pathway in both the cells.
Methods
Collection, extract and sample preparation of microalga
Microalgal sample were gather from various ponds in 
the Bankura district in the state of West Bengal, India in 
April 2014. This algal sample was authenticated by Dr. R. 
K. Gupta, Botanical Survey of India, Kolkata, India and 
preserved in formalin (4 %) for identification and noticed 
under the light microscope using standard methods [49]. 
The procedure of extract preparation of E. tuba followed 
exactly is same like previous [23]. The microalgal extract 
was taken and dissolved in sterile distilled water fol-
lowed by filter sterilization using 0.22  μm syringe filter 
and a stock of 2 mg/ml was prepared for conducting all 
experiments.
Cell lines and culture
Human lung adenocarcinoma (A549), human breast ade-
nocarcinoma (MCF-7) and human lung fibroblast (WI-
38) cell line were obtained from the National Centre for 
Cell Science (NCCS), India and kept in the ideal labora-
tory condition. A549 cells were cultured as monolayers 
in Ham’s F-12 medium whereas MCF-7 and WI-38 cells 
were cultured as monolayers in DMEM. Both the media 
were supplemented with 10  % (v/v) fetal bovine serum 
(FBS), 100  U/ml Penicillin G, 100  µg/ml Streptomycin, 
50  µg/ml Gentamycin sulphate and 2.5  µg/ml Ampho-
tericin B. All the cell lines were kept in a humidified 
atmosphere containing 5 % CO2 in incubator at 37 °C and 
passaged tri-weekly.
Determination of cytotoxicity using WST‑1 Assay
Cell viability were analysed using the WST-1 cell prolif-
eration reagent according to the earlier described tech-
nique [50]. All cells (1 × 104 cells/well) were treated for 
48  h with concentrations ranging from 0–200  µg/ml of 
ETME, ascorbic acid, catechin, tannic acid, reserpine, 
methyl gallate and rutin. Cell proliferation and viability 
were measured by measuring absorbance of the coloured 
product spectrophotometrically at 460 nm using a micro-
plate ELISA reader MULTISKAN EX (Thermo Electron 
Corporation, USA).
Cell cycle analysis
According to a previously described method, cell cycle 
analysis was studied by flow cytometry [50]. Cell cycle 
phase distribution of treated and untreated cells was 
examined by flow cytometry [FACS Verse (Becton–Dick-
inson) equipped with 405 nm (Violet), 488 nm (Blue) and 
640 nm (Red) solid state laser light using FACSuite soft-
ware Version 1.0.3.2942] by acquiring at least 10,000 cells 
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per sample. The percentage of populations in the G0/
G1, S and G2/M phases were determined using similar 
software.
Annexin V/propidium iodide staining
Apoptotic cells were quantified by Propidium iodide (PI) 
and Annexin V-FITC double staining, using an Annexin-
V-FLUOS Staining Kit, Roche Diagnostics according to 
manufacturer’s protocols. Treated and untreated cells 
were stained with PI and FITC according to the manu-
facturer protocol. The distribution of apoptotic cells was 
quantified by flow cytometer. A total 10,000 events were 
acquired.
DAPI (4′,6′‑diamidino‑2 phenylindole) staining
According to an earlier described method, cell morphol-
ogy was observed by DAPI staining [51]. The undergoing 
apoptosis cells, represented by the morphological altera-
tion of apoptotic nuclei, were observed and taken image 
from ten eye views at 630× magnifications under a laser 
scanning confocal microscope Leica TCS SP8 (Leica, 
Illinois, United States) and the data was analyzed using 
Leica Application Suite X software.
Immunoblot analysis
Both A549 and MCF-7 cells were treated with 200 and 
150 µg/ml ETME respectively for different time intervals 
(6–36 h) for testing apoptotic and MAPK related protein 
study. Protein was quantified by the Folin-Lowry method. 
Equal quantities of proteins (40 mg for apoptotic related 
and 30 mg for MAPK) were taken for gel electrophoresis. 
The blot was developed using the previous protocol [51]. 
The photographs were taken using imaging system EC3 
Chemi HR (UVP, USA). The developed blots were then 
analysed for densities of bands by ImageJ 1.45 s software.
Scratch motility assay
Both malignant cells were seeded and grown for over-
night to make confluent. The monolayer was then 
scratched vertically using pipette tip followed by washing 
with PBS two times to eliminate detached cells and incu-
bated with media containing extracts at their respective 
less-toxic dose for 48 h. After incubation, cells migration 
on these scratched zones was pictured at five randomly 
selected fields.
Gelatin zymography assay
MMP-9 activity was checked by gelatin zymography 
as described previously [52]. After 48  h treatment with 
several concentrations of ETME (0–200  µg/ml) both 
A549 and MCF-7 cells were harvested, total protein 
was isolated and gelatin gymography was performed. 
Appearance of unstained bands on a blue background, 
indicates gelatinolytic activity.
Measurement of intracellular ROS using DCFH‑DA staining
For DCFH-DA staining treated and untreated cells were 
washed with PBS and loaded with 20  µM DCFH-DA 
diluted in clear serum free media for 30  min at 37  °C. 
After that cells were washed twice with PBS and inten-
sity of the intracellular ROS was measured by FACS in all 
three cell lines and also morphology of cells (A549 and 
MCF-7 cells) was photographed (400× magnifications) 
using a previously mentioned laser scanning confocal 
microscope.
Measurement of antioxidants by different biochemical 
assays
After ETME treatment, all the cells were harvested and 
washed with PBS. The cell pellet was suspended in cold 
PBS and were lysed on ice using a sonicator and centri-
fuged at 13800g for 20 min at 4 °C. The supernatant was 
taken for testing antioxidant enzyme assays, such as SOD, 
CAT, GST and also measuring the production of GSH 
and TBARS. SOD as checked by measuring the inhibi-
tion of the formation of blue colour formazan at 560 nm 
with slight modification from a previous study [53]. CAT 
activity was measured with modified protocol continu-
ous time course decaying of H2O2 at 240 nm [54]. Earlier 
described method was followed to examine glutathione-
S-transferase GST based on the formation of GSH-
CDNB conjugate [55]. The reduced glutathione (GSH) 
level was determined spectrophotometrically at 412 nm 
according to the standard protocol [56]. The level of lipid 
peroxide in cell homogenates were determined in condi-
tions of thiobarbituric acid reactive substances (TBARS) 
as an index of accumulation of malondialdehyde [57]. All 
biochemical tests were assayed in hexaplate.
DNA and protein binding studies
DNA and protein binding characteristics of the com-
pounds present in ETME were investigated by UV–Visi-
ble spectroscopy using a Shimadzu UV-2401 PC UV–VIS 
recording spectrometer (Shimadzu Corporation, Kyoto, 
Japan) according to previously described method [58]. In 
addition, for protein binding study the fluorescence emis-
sion spectra was also measured at 25  °C. Spectra were 
recorded in the wavelength range of 200–500 nm setting 
the excitation at 288 nm, and emission at 340 nm accord-
ing to the previously described method [59].
Statistical analysis
All spectrophotometric data were presented as the mean 
six times ±SD and cell cycle and ROS analysis data by 
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FACS was introduced as the mean three times ±SD. 
The statistical analysis was determined by KyPlot ver-
sion 2.0 beta 15 (32 bit). When A1 = IC50, Y = response 
(Y = 100 % when X = 0), X = inhibitory concentration, 
then IC50 values were calculated by the following formula, 
Y = 100 ∗ A1
/
(X + A1). The IC50 values were compared 
by paired t test. P < 0.05 was considered significant.
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